We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
The Vurger Co aim to revolutionise the fast food industry with their 100% plant based burgers. They have run a number of successful pop up shops and are now looking to bring the plant based revolution to London with their first restaurant. 
days to go: Expired investment: £299,760
HUN Wines sources premium quality wine from Stellenbosch, South Africa, to create the UK's first Fairtrade, wine in a can. It aims to become the largest canned wine brand in the world. The company asserts that its products are fully recyclable and vegan friendly. HUN Wines claims that it is backed by industry titans including James Bailey, current Waitrose CEO, Andy Shaw, previously Brewdog Beer CEO and RedBull MD, Formula racing legend David Coulthard and RedBull executives. The company has successfully canned 300,000 units of its products consisting of flavours like Rosé, Sauvignon Blanc, and Rosé Bubbles (one of the lowest-calorie wines in the UK). It accepted its first order via a Direct-to-Consumer (DTC) site in May 2020, launched nationwide in Tesco Supermarkets in June and expanded onto the e-commerce platform, Amazon, in July. HUN Wines will use 15% of the investment towards staff expenses, 40% towards marketing, 25% towards festival activations and listings, and 20% towards New Product Development (NPD).

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £600,761
Forth allows users to track their wellbeing to see what impact their lifestyle is having on their health. It allows users to maximise their performance during athletics, keep track of their inner health and focus on things they may need to work on for greater overall wellbeing. 
days to go: Expired investment: £165,760
Tribal Sports Nutrition is a real food active nutrition company.  They are focused on bring the baobab fruit from Africa to everyday lives in the form of a fruit smoothie.  The investment will enable Tribal to unlock their global potential.
days to go: Expired investment: £149,310
MenuLab helps food businesses track allergens in the food they serve to customers via a smartphone app. 
days to go: Expired investment: £1,989
Tribal Sports Nutrition (TSN) uses the revitalising properties of the Baobab fruit to create energy smoothies. TSN claims that its smoothies are less concentrated than other sports nutrition brands, are 100% organic, and easy on the stomach. The company also incorporates vitamin C, antioxidants, fibre, and electrolytes into the smoothies to make it the on-the-go snack for active lifestyle consumers. TSN asserts that its baobab ingredient is wild-harvested by cooperatives in Africa, bringing income to people and preserving the local ecology. The company received a certification from the Organic Food Federation (OFF) and aims to achieve B Corp status. TSN's products have been listed in Sainsbury's and on Amazon. It will use the investment to double its existing product offering in 2021 and launch hydration, plant protein recovery products, and Baobab energy snacks.

Pitch Rated

86%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £421,647
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph